Streetbeat News

Earnings

GRTX

Galera Therapeutics (NASDAQ:GRTX) reported a Q4 EPS loss of $(0.10), surpassing the analyst consensus estimate of $(0.35) by 71.43%. This represents an 82.76% improvement over the $(0.58) per share loss from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:15 am

ATAI

ATAI Life Sciences (NASDAQ:ATAI) reported Q4 earnings with EPS of $(0.12), beating the $(0.16) estimate, but missed sales estimates with $18.00K versus the expected $190.00K. This represents a 57.14% increase in EPS and a 52.63% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:14 am

WBA

Walgreens Boots Alliance (WBA) shares increased following the announcement of Q2 FY24 earnings surpassing expectations and an update to FY24 guidance.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:10 am

RGNX

REGENXBIO Inc. (NASDAQ:RGNX) announced the publication of Phase I/IIa trial results for ABBV-RGX-314, a gene therapy for wet AMD, in The Lancet. The study, showing positive results for safety and tolerability, supports ongoing pivotal trials of this potential one-time treatment.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:09 am

WBA

Walgreens Boots Alliance (WBA) reported Q2 adjusted EPS of $1.20, surpassing the $0.82 estimate, a 46.34% beat. Sales reached $37.05B, exceeding the $35.86B estimate by 3.32%, marking a 6.28% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:08 am

APLM

Apollomics (NASDAQ:APLM) reported a significant improvement in its fiscal year earnings, with a quarterly loss of $(2.32) per share, a 72.51% increase from the $(8.44) per share loss reported in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:06 am

MLKN

MillerKnoll reported mixed Q3 financial results and provided Q4 guidance for adjusted EPS and revenue that fell below analyst estimates, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:06 am

QBTS

D-Wave Quantum reported a 34% year-over-year increase in Q4 bookings, totaling $3.1M, marking its seventh consecutive quarter of growth.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:05 am

WBA

Walgreens Boots Alliance (WBA) has announced that for FY2024, it expects its U.S. Healthcare Adjusted EBITDA to be breakeven at the midpoint of its guidance range, which spans from a loss of $50 million to a gain of $50 million.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:05 am

DTST

Data Storage Corporation (DTST) reported a significant improvement in its financial performance for FY23, with earnings per share (EPS) of $0.05, compared to a loss of $(0.64) per share in the previous year. The company's revenue for FY23 totaled $24.96 million, marking an increase from $23.87 million year-over-year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:05 am